
Moderna Inc. said a preliminary analysis of its Covid-19 vaccine suggested it’s almost 95% effective. It was another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control the pandemic.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push